RILIPRUBART
UNII I31869XDP8

Substance Identification & Data

This profile provides standardized clinical and technical data for Riliprubart, uniquely identified by the FDA Unique Ingredient Identifier (UNII) I31869XDP8.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2756228-76-7 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

I31869XDP8

CAS Registry Number

2756228-76-7

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

RILIPRUBART

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C199103

National Cancer Institute reference terminology for clinical and research data.

INN ID

12577

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

MN-38

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Riliprubart. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

RILIPRUBART

Common Names & Synonyms

ANTI-C1S HUMANIZED IGG4 MONOCLONAL ANTIBODY

IMMUNOGLOBULIN G4 (224-PROLINE,234-GLUTAMIC ACID,427-LYSINE,433-SERINE), ANTI-(HUMAN COMPLEMENT C1S) (HUMAN-MUS MUSCULUS MONOCLONAL SAR445088 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL SAR445088 .KAPPA.-CHAIN, DIMER

IMMUNOGLOBULIN G4-KAPPA, ANTI-(HOMO SAPIENS C1S (COMPLEMENT C1S)), MONOCLONAL ANTIBODY; GAMMA4 HEAVY CHAIN (1-446) (VH MUSMUS/HOMSAP (MUS MUSCULUS IGHV14-3*02 (82.7%) -(IGHD) -IGHJ2*01 (92.9%)/HOMO SAPIENS IGHV1-46*02 (75.5%) -(IGHD) -IGHJ4*01 (92.9%) L123>T (114)), CDR-IMGT (8.8.12) (26-33.51-58.97-108)) (1-119) -HOMO SAPIENS IGHG4*01, NG4M(A) CH2 L92, G4V5 H P10, G4V3 CH2 E1.2, G4V24 CH3 L107, S114 (CH1 (120-217), HINGE 1-12 S10>P (227) (218-229), CH2 L1.2>E (234), L92 (308) (230-339), CH3 M107>L (427), N114>S (433) (340-444), CHS (445-446)) (120-446)), (133-218')-DISULFIDE WITH KAPPA LIGHT CHAIN (1'-218') (V-KAPPA MUSMUS/HOMSAP (MUS MUSCULUS IGKV3-4*01 (88.9%) -IGKJ1*01 (91.7%)/HOMO SAPIENS IGKV4-1*01 (74.3%) -IGKJ4*01 (100%)), CDR-IMGT (10.3.9) (27-36.54-56.93-101)) (1'-111') -HOMO SAPIENS IGKC*01 (100%), KM3 A45.1 (157), V101 (195) (112'-218')); DIMER (225-225'':228-228'')-BISDISULFIDE, PRODUCED IN CHINESE HAMSTER OVARY (CHO) CELLS, GLYCOFORM ALFA

RILIPRUBART [INN]

RILIPRUBART [USAN]

SAR445088